4,069
Views
16
CrossRef citations to date
0
Altmetric
Diabetes

Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden

&
Pages 997-1005 | Received 05 Feb 2019, Accepted 28 Apr 2019, Published online: 23 May 2019